NIAID AND MEDIMMUNE JOIN FORCES TO DEVELOP POTENTIAL PANDEMIC INFLUENZA VACCINES

HHS Secretary Mike Leavitt today announced that the National Institute of Allergy and Infectious Diseases (NIAID) and MedImmune Inc. have signed a cooperative research and development agreement for the development of vaccines against avian influenza viruses that have the potential to cause pandemics. Under the agreement, NIAID, part of the National Institutes of Health, and MedImmune of Gaithersburg, Md., will produce and test multiple vaccines against potential pandemic flu strains, including the H5N1 avian influenza virus.
PR Newswire